293 related articles for article (PubMed ID: 30646616)
1. Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.
Pan D; Chen J; Feng C; Wu W; Wang Y; Tong J; Zhou D
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646616
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
3. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
[TBL] [Abstract][Full Text] [Related]
4. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
[TBL] [Abstract][Full Text] [Related]
5. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
6. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
Clark DJ; Fondrie WE; Yang A; Mao L
J Proteomics; 2016 Feb; 133():161-169. PubMed ID: 26739763
[TBL] [Abstract][Full Text] [Related]
7. The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications.
Zheng H; Zhan Y; Liu S; Lu J; Luo J; Feng J; Fan S
J Exp Clin Cancer Res; 2018 Sep; 37(1):226. PubMed ID: 30217217
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Protein Profiling and mRNA Expression of LLC Exosomes.
Zhang W; He P; Wang S; Adili A; Chen Z; Zhang CY; Jiang X; Li J; Zhang Y
Protein J; 2019 Oct; 38(5):586-597. PubMed ID: 31214853
[TBL] [Abstract][Full Text] [Related]
9. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
11. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
12. Exosomal proteins as prognostic biomarkers in non-small cell lung cancer.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Bæk R; Jakobsen KR; Meldgaard P; Folkersen BH; Rasmussen TR; Varming K; Jørgensen MM; Sorensen BS
Mol Oncol; 2016 Dec; 10(10):1595-1602. PubMed ID: 27856179
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Park JO; Choi DY; Choi DS; Kim HJ; Kang JW; Jung JH; Lee JH; Kim J; Freeman MR; Lee KY; Gho YS; Kim KP
Proteomics; 2013 Jul; 13(14):2125-34. PubMed ID: 23585444
[TBL] [Abstract][Full Text] [Related]
14. Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer.
Wang N; Song X; Liu L; Niu L; Wang X; Song X; Xie L
Cancer Sci; 2018 May; 109(5):1701-1709. PubMed ID: 29573061
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
16. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
[TBL] [Abstract][Full Text] [Related]
18. Autosomal Tubulointerstitial Kidney Disease-MUC1 Type: Differential Proteomics Suggests that Mutated MUC1 (insC) Affects Vesicular Transport in Renal Epithelial Cells.
Staubach S; Wenzel A; Beck BB; Rinschen MM; Müller S; Hanisch FG
Proteomics; 2018 Apr; 18(7):e1700456. PubMed ID: 29436780
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
20. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
